ENOV Straddle Strategy
ENOV (Enovis Corporation), in the Healthcare sector, (Medical - Devices industry), listed on NYSE.
Enovis Corporation is a global medical technology enterprise specializing in the design, production, and supply of medical devices. These specialized products are instrumental for a diverse range of healthcare professionals—including orthopedic specialists, surgeons, general physicians, pain management experts, physical therapists, podiatrists, chiropractors, and athletic trainers—who treat patients with musculoskeletal conditions resulting from degenerative illnesses, deformities, traumatic events, or sports-related injuries. The company's extensive product line encompasses rigid and flexible orthopedic supports, thermal and cryotherapy items, bone growth stimulation devices, vascular therapy systems paired with compression garments, therapeutic footwear and orthotics, electrical stimulators for pain alleviation, and physical rehabilitation equipment. Additionally, Enovis provides a comprehensive array of reconstructive joint implants for areas such as the hip, knee, shoulder, elbow, foot, ankle, and fingers. Enovis Corporation distributes its products through a network of independent channels, including healthcare providers, retail establishments, and pharmacies, in addition to direct sales under its prominent DJO brand. Previously known as Colfax Corporation, the company is headquartered in Wilmington, Delaware.
ENOV (Enovis Corporation) trades in the Healthcare sector, specifically Medical - Devices, with a market capitalization of approximately $1.42B, a beta of 1.45 versus the broader market, a 52-week range of 19.14-34.28, average daily share volume of 1.1M, a public-listing history dating back to 2008, approximately 8K full-time employees. These structural characteristics shape how ENOV stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.45 indicates ENOV has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a straddle on ENOV?
A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration.
ENOV snapshot
As of August 14, 2026, spot at $26.22, ATM IV 61.40%, IV rank 24.86%, expected move 17.60%. The straddle on ENOV below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this straddle structure on ENOV specifically: ENOV IV at 61.40% is on the cheap side of its 1-year range, which favors premium-buying structures like a ENOV straddle, with a market-implied 1-standard-deviation move of approximately 17.60% (roughly $4.62 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ENOV expiries trade a higher absolute premium for lower per-day decay. Position sizing on ENOV should anchor to the underlying notional of $26.22 per share and to the trader's directional view on ENOV stock.
ENOV straddle setup
The ENOV straddle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ENOV at $26.22 on that close, the first option leg uses a $26.22 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ENOV chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ENOV shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $26.22 | N/A |
| Buy 1 | Put | $26.22 | N/A |
ENOV straddle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit.
ENOV straddle payoff curve
Modeled P&L at expiration across a range of underlying prices for the straddle on ENOV. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use straddle on ENOV
Straddles on ENOV are pure-volatility plays that profit from large moves in either direction; traders typically buy ENOV straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
ENOV thesis for this straddle
The market-implied 1-standard-deviation range for ENOV extends from approximately $21.60 on the downside to $30.84 on the upside. A ENOV long straddle is a pure-volatility play: it profits when the underlying moves far enough from the strike in either direction to overcome the combined call plus put debit, regardless of direction. Current ENOV IV rank near 24.86% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on ENOV at 61.40%. As a Healthcare name, ENOV options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ENOV-specific events.
ENOV straddle positions are structurally neutral / high-volatility (long premium); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ENOV positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ENOV alongside the broader basket even when ENOV-specific fundamentals are unchanged. Always rebuild the position from current ENOV chain quotes before placing a trade.
Frequently asked questions
- What is a straddle on ENOV?
- A straddle on ENOV is the straddle strategy applied to ENOV (stock). The strategy is structurally neutral / high-volatility (long premium): A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration. With ENOV stock at $26.22 on the most recent close, the strikes shown on this page are snapped to the nearest listed ENOV chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are ENOV straddle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the ENOV straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 61.40%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a ENOV straddle?
- The breakeven for the ENOV straddle priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The ENOV market-implied 1-standard-deviation expected move in the same options snapshot is approximately 17.60%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a straddle on ENOV?
- Straddles on ENOV are pure-volatility plays that profit from large moves in either direction; traders typically buy ENOV straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
- How does current ENOV implied volatility affect this straddle?
- ENOV ATM IV is at 61.40% with IV rank near 24.86%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.